Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Zanichelli

Showing results (11-20 of 119) with videos related to

Pageof 12
Sort By:
Expert Opinion on Pharmacotherapy|October 30, 2015
Current treatment options for hereditary angioedema due to C1 inhibitor deficiencyMaddalena Alessandra Wu, Andrea Zanichelli, Marta Mansi, et al.
Internal and Emergency Medicine|August 4, 2010
Treatment of acquired angioedema with icatibant: a case reportAndrea Zanichelli, Matteo Badini, Ilaria Nataloni, et al.
European Journal of Internal Medicine|March 12, 2022
Health-care associated infections surveillance in elderly patientsAndrea Zanichelli, Stefano Pietro Sgobba, Andrea Merlo, et al.
Springer Seminars in Immunopathology|November 4, 2005
C1 inhibitor: molecular and clinical aspectsMarco Cicardi, Lorenza Zingale, Andrea Zanichelli, et al.
Trends in Molecular Medicine|January 24, 2009
C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progressMassimo Cugno, Andrea Zanichelli, Fabrizio Foieni, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 14, 2013
Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in EuropeAndrea Zanichelli, Markus Magerl, Hilary Longhurst, et al.
Expert Opinion on Biological Therapy|December 12, 2024
New drugs for the treatment of hereditary angioedemaGiulia Costanzo, Giada Sambugaro, Silvio Sartorio, et al.
Journal of Immunological Methods|October 2, 2025
Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimizationChiara Suffritti, Roberta Gualtierotti, Andrea Zanichelli, et al.
Expert Review of Clinical Immunology|November 14, 2019
Lanadelumab for the prevention of attacks in hereditary angioedemaAnna Valerieva, Riccardo Senter, Maddalena Alessandra Wu, et al.
Frontiers in Allergy|August 12, 2022
Real-Life Experience With Subcutaneous Plasma-Derived C1-Inhibitor for Long-Term Prophylaxis in Patients With Hereditary Angioedema: A Case SeriesAndrea Zanichelli, Chiara Suffritti, Valentina Popescu Janu, et al.
Pageof 12

Showing results (11-20 of 119) with videos related to

Sort By:
Pageof 12
Expert Opinion on Pharmacotherapy|October 30, 2015
Current treatment options for hereditary angioedema due to C1 inhibitor deficiencyMaddalena Alessandra Wu, Andrea Zanichelli, Marta Mansi, et al.
Internal and Emergency Medicine|August 4, 2010
Treatment of acquired angioedema with icatibant: a case reportAndrea Zanichelli, Matteo Badini, Ilaria Nataloni, et al.
European Journal of Internal Medicine|March 12, 2022
Health-care associated infections surveillance in elderly patientsAndrea Zanichelli, Stefano Pietro Sgobba, Andrea Merlo, et al.
Springer Seminars in Immunopathology|November 4, 2005
C1 inhibitor: molecular and clinical aspectsMarco Cicardi, Lorenza Zingale, Andrea Zanichelli, et al.
Trends in Molecular Medicine|January 24, 2009
C1-inhibitor deficiency and angioedema: molecular mechanisms and clinical progressMassimo Cugno, Andrea Zanichelli, Fabrizio Foieni, et al.
Allergy, Asthma, and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology|August 14, 2013
Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in EuropeAndrea Zanichelli, Markus Magerl, Hilary Longhurst, et al.
Expert Opinion on Biological Therapy|December 12, 2024
New drugs for the treatment of hereditary angioedemaGiulia Costanzo, Giada Sambugaro, Silvio Sartorio, et al.
Journal of Immunological Methods|October 2, 2025
Measurement of cleaved high-molecular-weight kininogen in patients with hereditary angioedema due to C1-inhibitor deficiency: preanalytical and analytical optimizationChiara Suffritti, Roberta Gualtierotti, Andrea Zanichelli, et al.
Expert Review of Clinical Immunology|November 14, 2019
Lanadelumab for the prevention of attacks in hereditary angioedemaAnna Valerieva, Riccardo Senter, Maddalena Alessandra Wu, et al.
Frontiers in Allergy|August 12, 2022
Real-Life Experience With Subcutaneous Plasma-Derived C1-Inhibitor for Long-Term Prophylaxis in Patients With Hereditary Angioedema: A Case SeriesAndrea Zanichelli, Chiara Suffritti, Valentina Popescu Janu, et al.
Pageof 12